The microbiome in bronchiectasis
Bronchiectasis is increasing in prevalence worldwide, yet current treatments available are limited to those alleviating symptoms and reducing exacerbations. The pathogenesis of the disease and the inflammatory, infective and molecular drivers of disease progression are not fully understood, making t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-09-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/28/153/190048.full |